A Careful, Honest Comparison
ChondroFiller® vs
Hyaluronic Acid
Both are clinic-delivered, ultrasound-guided injections — but they do completely different jobs. ChondroFiller® is a regenerative scaffold for a defined cartilage defect; hyaluronic acid is a joint lubricant that improves comfort for a few months. Here is the honest comparison.
Reviewed byProf Paul Lee MBBch, FRCS (Tr & Orth), PhDLast reviewed 1 May 2026Quick Answer
ChondroFiller® supports cartilage regeneration in a focal defect; hyaluronic acid (HA) lubricates a whole joint to reduce symptoms. HA is the most common viscosupplement in the UK (Durolane, Synvisc, Ostenil, Hyalgan and others), typically given as a single injection or a short course for mild-to-moderate knee osteoarthritis. Effects last around six months. ChondroFiller® is a different proposition entirely — a collagen scaffold that fills a focal cartilage defect so the body’s own cells can rebuild tissue over six to twelve months, with maintained outcomes at five years and beyond. They are not interchangeable, and they are priced for different commitments.
The Headline Difference
ChondroFiller® vs Hyaluronic Acid — the key difference
Hyaluronic acid is a viscosupplement: a thick, lubricating fluid injected into the joint cavity to improve gliding and dampen pain signalling for a few months. It does not enter or fill a cartilage defect, and it is not regenerative. ChondroFiller® works the other way around — a sterile collagen scaffold is placed directly into a defined cartilage defect under ultrasound guidance, and the patient’s own cells then migrate in to lay down new cartilage matrix. Different mechanism, different target, different time horizon.
Mechanism of Action
How each treatment works
ChondroFiller® is a sterile type I/III collagen scaffold injected as a liquid directly into a mapped cartilage defect under ultrasound guidance. It sets into a gel that occupies the defect within minutes.
The patient’s own cells then migrate into the scaffold and lay down new cartilage matrix over six to twelve months. ChondroFiller® is structural and regenerative — it actually fills the defect.
Hyaluronic acid is a naturally occurring component of synovial fluid. Viscosupplement injections deliver a manufactured form (or in some products a crosslinked or higher-molecular-weight form) into the joint cavity, usually under ultrasound guidance.
The gel improves the joint’s lubrication and may dampen pain signalling for a few months. HA does not regenerate cartilage, does not fill a defect and does not alter the joint surface.
How Long Results May Last
Duration and number of injections
Tissue formation over 6–12 months
≈ 6 months per course
Direct duration comparison is misleading. ChondroFiller® aims to rebuild tissue in a defined defect, HA aims to make a whole joint more comfortable for a few months. They are measuring different things.
Treatment Course
Number of injections
Typically one injection course, with the box quantity (one, two or three) decided from MRI: one box treats most defects up to roughly 2 cm², two or three for larger or multi-zone defects. A second course is rarely needed if the original tissue establishes.
HA is most often given as either a single injection (longer-acting crosslinked products such as Durolane, or single-dose protocols of other brands) or a course of three to five weekly injections. Repeat courses are commonly scheduled every six to twelve months in responders.
Safety and Infection
Safety considerations
Both are outpatient injections with low overall complication rates. ChondroFiller® at London Cartilage Clinic is delivered under real-time ultrasound guidance with full sterile technique and routine IV antibiotic cover; the most serious risk is joint infection, which is rare.
HA is one of the most commonly delivered MSK injections in the UK with a well-documented safety profile — transient post-injection inflammation (a so-called pseudoseptic reaction) is the most reported side effect, and joint infection is rare when sterile technique is observed. Ultrasound guidance improves placement accuracy regardless of product.
Patient Selection
Who each treatment may suit
Hyaluronic acid is most defensible in mild-to-moderate knee osteoarthritis where symptom relief over a few months is the goal, particularly in patients with whole-joint symptoms rather than a single focal defect. Some patients respond well to repeat courses for several years before considering more invasive options.
ChondroFiller® is for patients with a focal cartilage defect on MRI — typically up to around 6 cm² with reasonably preserved surrounding cartilage. It is a defect-targeted treatment, not a whole-joint symptom modulator. See who is suitable for ChondroFiller?
Many patients are clearly one or the other on imaging. Some sit between the two; the decision is made at consultation with imaging review, not at booking.
Cost and Value
What each treatment costs
At London Cartilage Clinic, ChondroFiller® costs from £3,000 for one box, £5,500 for two and £8,000 for three, all-in. See the ChondroFiller® cost guide.
Hyaluronic acid in the UK is typically priced per injection at £200–£500, with a course of three to five injections therefore running around £600–£1,500. Single-dose crosslinked products sit at the higher end of the per-injection range. NHS funding for HA knee viscosupplementation is limited and varies by region.
The headline gap is meaningful, but the treatments are not interchangeable. Pricing should not drive the clinical decision — what the imaging shows should.
Our Honest Take
When we may recommend each
You have a focal cartilage defect on MRI with reasonably preserved surrounding tissue.
You want a regenerative pathway that supports natural cartilage formation rather than a symptom-only modulator.
HA has been tried previously, has helped only briefly or not at all, and the imaging now shows a focal defect.
Mild-to-moderate knee osteoarthritis with whole-joint symptoms, where short-to-medium-term symptom relief is the goal.
A patient unwilling to commit to a more invasive or higher-cost regenerative pathway, and willing to accept that HA is symptom relief rather than tissue repair.
As a bridging option while imaging, monitoring and consultation pin down whether a structural treatment is needed.
When Each Is The Wrong Answer
When we would not recommend each
Diffuse whole-joint osteoarthritis with no focal defect — a viscosupplement or another modality may be the better step.
Active infection or unwillingness to accept the conservative safety protocol.
A patient with a clear focal cartilage defect on MRI where a scaffold (ChondroFiller®) is the more direct regenerative step.
Patients expecting HA to regenerate cartilage — HA is a lubricant, not a structural therapy.
End-stage bone-on-bone disease where neither a viscosupplement nor a scaffold is likely to deliver meaningful benefit and replacement may be the right answer.
The Bottom Line
In summary
ChondroFiller® and hyaluronic acid look superficially similar — both are ultrasound-guided clinic injections — but they do completely different jobs. HA lubricates a whole joint for a few months; ChondroFiller® fills a focal cartilage defect and supports new tissue formation for years. The right answer comes from imaging, not from price or category. We are happy to recommend HA, no treatment, or a different pathway entirely when that is the honest answer.
ChondroFiller® vs Hyaluronic Acid
Frequently asked questions
Can I have ChondroFiller® and hyaluronic acid?
They are not usually combined in the same procedure. Where a patient has had HA already and the imaging shows a focal cartilage defect, ChondroFiller® can sometimes be the next step. The order and any combination are decided at consultation with imaging review.
Which one regenerates cartilage?
ChondroFiller® supports natural cartilage regeneration by providing a scaffold for the body’s cells to lay down new matrix over six to twelve months. Hyaluronic acid does not regenerate cartilage; it is a viscosupplement that lubricates the joint to reduce symptoms.
Which has more clinical evidence?
Hyaluronic acid has by far the longer publication record because it has been used in MSK practice for decades; the strength of that evidence varies by product and indication, and UK and US guideline bodies are split on whether to recommend it routinely for knee OA. ChondroFiller® has a younger but cartilage-specific outcome record (IKDC, Harris Hip Score, MOCART MRI) with over 19,000 cases of clinical use across joints. See the ChondroFiller® clinical evidence page.
Why is ChondroFiller® so much more expensive than HA?
The two products solve different problems and have different cost bases. HA is a well-established viscosupplement injected as a course; ChondroFiller® is a sterile collagen scaffold that fills a cartilage defect and supports new tissue formation over months. The price difference reflects what each treatment is and what it aims to do — not a discounted version of the same thing.
I have been having HA injections for years. Should I switch?
Not necessarily. If HA continues to provide useful relief and the imaging does not show a focal defect that would benefit from a scaffold, staying on HA can be a sensible plan. Where HA has stopped helping, or where the imaging now shows a defined cartilage defect, ChondroFiller® can be a reasonable next step. We review the current MRI before recommending.
Is hyaluronic acid available on the NHS?
NHS funding for hyaluronic acid knee viscosupplementation is limited and varies by region and commissioning policy. Some pain clinics and integrated MSK services offer it within structured pathways; others do not. ChondroFiller® is not routinely funded by the NHS in the UK and is a private treatment at this time.
Book a ChondroFiller® Assessment – London
Natural cartilage regeneration starts with the right defect, the right operator, and the right plan.
Learn More about ChondroFiller
Deep dive into our clinical resources and patient guides.
Cost in the UK
ChondroFiller® cost in the UK from £3,000, what is included and why prices vary.
Suitability
Who is suitable for ChondroFiller® as an injection, and who may need caution.
Clinical Evidence
IKDC, Harris Hip Score and MOCART MRI outcomes for ChondroFiller® cartilage regeneration.
Self-Assessment
Five-question ChondroFiller® pathway self-assessment for Prevention, Regeneration, Combination, or Support.
In London
Private ChondroFiller® cartilage repair at our Harley Street clinic.
Liquid Cartilage™ Surgery
Our proprietary keyhole-surgery technique combining ChondroFiller® with MSC co-delivery in a single procedure, for larger or more complex cartilage defects. £9,800.
ChondroFiller vs Arthrosamid
Cartilage regeneration vs joint cushioning, two very different injections.
ChondroFiller vs Hyaluronic Acid
Structural scaffold for cartilage regeneration vs joint-lubricant viscosupplement.
ChondroFiller vs Microfracture
ChondroFiller® regeneration compared to microfracture surgery for cartilage defects.
ChondroFiller vs MACI
ChondroFiller® scaffold compared to matrix-induced autologous chondrocyte implantation.
ChondroFiller vs ACI
ChondroFiller® scaffold compared to the original autologous chondrocyte implantation technique.
ChondroFiller vs PRP
ChondroFiller® cartilage regeneration compared to platelet-rich plasma injection.
ChondroFiller vs Stem Cells
ChondroFiller® compared to stem cell and biologic regenerative treatments.
ChondroFiller vs Knee Replacement
Where ChondroFiller® may help preserve the joint and where replacement is the right answer.
ChondroFiller® Injection
Cartilage Regeneration Overview
ChondroFiller® is a registered trademark of Meidrix Biomedicals GmbH. London Cartilage Clinic is not affiliated with or endorsed by Meidrix Biomedicals.